AMP functionalized curdlan nanoparticles as a siRNA carrier: Synthesis, characterization and targeted delivery via adenosine A2B receptor

Int J Biol Macromol. 2021 Dec 15;193(Pt A):866-873. doi: 10.1016/j.ijbiomac.2021.10.138. Epub 2021 Oct 29.

Abstract

Receptor-mediated endocytosis has been used for tissue targeted delivery of short interfering RNA (siRNA) drugs. Herein, we investigated adenosine receptor (AR) as a candidate for receptor-mediated siRNA internalization. We synthesized adenosine functionalized cationic curdlan derivatives (denote CuAMP polymers). One of these polymers, CuAMP4, efficiently delivered siRNA to breast cancer cells expressing high level of A2B receptor. The internalization of siRNA loaded CuAMP4 by cancer cells was inhibited by free AMP as well as endocytosis inhibitors. Moreover, knockdown of A2BR by siRNA, or pre-treatment of the cells with anti-A2BR antibody, strongly inhibited the cellular uptake of CuAMP4. Our findings confirmed that A2BR can be utilized for cell type specific siRNA delivery, and CuAMP4 NP may be a promising delivery system for cancer cell targeted delivery of therapeutic siRNAs.

Keywords: Curdlan; Receptor-mediated endocytosis; siRNA delivery.

MeSH terms

  • Adenosine Monophosphate / pharmacology*
  • Animals
  • Cell Line, Tumor
  • Humans
  • Mice
  • Nanoparticles
  • RNA, Small Interfering / metabolism
  • Receptor, Adenosine A2B / metabolism*
  • beta-Glucans / pharmacology*

Substances

  • ADORA2B protein, human
  • RNA, Small Interfering
  • Receptor, Adenosine A2B
  • adora2b protein, mouse
  • beta-Glucans
  • Adenosine Monophosphate
  • curdlan